Company Search:
Advanced Search
Sponsored Links
Kangmei Pharmaceutical Co Ltd Company Snapshot
Kangmei Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kangmei Pharmaceutical Co Ltd with three other companies in this sector in China: Apeloa Pharmaceutical Co Ltd (2016 sales of 4.77 billion Chinese Renmimbi [US$757.64 million] of which 100% was Health Care & Pharmaceutical), Zhejiang Nhu Co Ltd (4.70 billion Chinese Renmimbi [US$745.91 million] of which 96% was Pharmaceutical Chemicals), and China Resources Double-Crane Pharmaceutical Company Limited (5.49 billion Chinese Renmimbi [US$872.36 million] of which 62% was Non- transfusion).

Sales Analysis. Kangmei Pharmaceutical Co Ltd reported sales of 21.61 billion Chinese Renmimbi (US$3.43 billion) for the year ending December of 2016. This represents an increase of 19.8% versus 2015, when the company's sales were 18.03 billion Chinese Renmimbi. Sales at Kangmei Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 255%). Sales of Other (Main) saw an increase that was more than double the company's growth rate: sales were up 1,198.2% in 2016, from 72.65 million Chinese Renmimbi to 943.17 million Chinese Renmimbi. Not all segments of Kangmei Pharmaceutical Co Ltd experienced an increase in sales in 2016: sales of Other Operation fell 89.7% to 66.58 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kangmei Pharmaceutical Co Ltd
  Stock Performance Chart for Kangmei Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 21.54
(Figures in Chinese Renmimbi)
1 Week -2.1%   13 Weeks -3.2%  
4 Weeks 0.1%   52 Weeks 10.2%  
Kangmei Pharmaceutical Co Ltd Key Data:
  Ticker: 600518 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 21,611,472,826
(Year Ending Jan 2017).
Employees: 10,037
  Currency: Chinese Renmimbi Market Cap: 106,128,736,160
  Fiscal Yr Ends: December Shares Outstanding: 4,927,053,675
  Share Type: A Gu Closely Held Shares: 2,521,162,427
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.